Wir verwenden Cookies und Analyse-Tools, um die Nutzerfreundlichkeit der Internet-Seite zu verbessern und für Marketingzwecke. Wenn Sie fortfahren, diese Seite zu verwenden, nehmen wir an, dass Sie damit einverstanden sind. Zur Datenschutzerklärung.
Insulin Analog
CHF 48.65
Auf Lager
SKU
94I6FAVR4I7
1 Verfügbar 
Geliefert zwischen Mi., 18.02.2026 und Do., 19.02.2026
Details
An insulin analog is an altered form of insulin, different from any occurring in nature, but still available to the human body for performing the same action as human insulin in terms of glycemic control. Through genetic engineering of the underlying DNA, the amino acid sequence of insulin can be changed to alter its ADME (absorption, distribution, metabolism, and excretion) characteristics. Officially, the U.S. Food and Drug Administration (FDA) refers to these as "insulin receptor ligands", although they are more commonly referred to as insulin analogs. These modifications have been used to create two types of insulin analogs: those that are more readily absorbed from the injection site and therefore act faster than natural insulin injected subcutaneously, intended to supply the bolus level of insulin needed after a meal; and those that are released slowly over a period of between 8 and 24 hours, intended to supply the basal level of insulin for the day. Insulin analog was first manufactured by Eli Lilly and Company.
Weitere Informationen
- Allgemeine Informationen
- GTIN 09786130293932
- Editor Frederic P. Miller, Agnes F. Vandome, John McBrewster
- Sprache Englisch
- Größe H220mm x B150mm x T6mm
- Jahr 2010
- EAN 9786130293932
- Format Fachbuch
- ISBN 978-613-0-29393-2
- Titel Insulin Analog
- Untertitel Insulin, Genetic engineering, Peptide sequence, ADME, DNA, Insulin lispro, Eli Lilly and Company, NPH insulin, Insulin aspart, Food and Drug Administration (United States)
- Gewicht 177g
- Herausgeber Alphascript Publishing
- Anzahl Seiten 108
- Genre Biologie
Bewertungen
Schreiben Sie eine Bewertung
